TopFunds

CVS Health Corporation

NYSE: CVS

Stock price

92.36 USD

(+0%) TODAY

Medical - Healthcare Plans
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.6
4.9
6.4
(0.6)
5.1
5.5
6
3.3
6.5
3.7
1.4
(11.3)%
02Free cash flow per share
5.5
7.3
5.9
6.5
8
10.2
11.8
10.2
8.1
5
6.1
1.2%
03Dividends per share
1.4
1.7
2
2
2
2
2
2.2
2.4
2.7
2.7
6.6%
04Dividends payout, %
30.1%
34.6%
30.9%
(3.4)%
39.2%
36.6%
32.8%
67.4%
37.5%
73.1%
1.9%
(24.1)%
PROFIT AND LOSS STATEMENT
05Revenue
153,290
177,546
184,786
194,579
256,776
268,706
292,111
322,467
357,776
372,809
402,067
10.1%
06% Change
-
-
-
-
-
-
-
-
-
-
-
10.1%
07Cost of revenue
(126,762)
(148,712)
(156,258)
(163,041)
(211,248)
(219,660)
(239,991)
(267,965)
(303,345)
(321,408)
(346,705)
10.6%
08Gross profit
26,528
28,834
28,528
31,538
45,528
49,046
52,120
54,502
54,431
51,401
55,362
7.6%
09% Margin
17.3%
16.2%
15.4%
16.2%
17.7%
18.3%
17.8%
16.9%
15.2%
13.8%
13.8%
16.2% A
10Operating expenses
(17,053)
(18,448)
(18,990)
(27,517)
(33,541)
(35,135)
(38,810)
(46,548)
(40,688)
(42,885)
(44,977)
10.2%
11% of Revenue
(11.1)%
(10.4)%
(10.3)%
(14.1)%
(13.1)%
(13.1)%
(13.3)%
(14.4)%
(11.4)%
(11.5)%
(11.2)%
(12.2)% A
12Operating Income
9,475
10,386
9,538
4,021
11,987
13,911
13,310
7,954
13,743
8,516
10,385
0.9%
13Income tax expense
(3,386)
(3,317)
(1,637)
(2,002)
(2,366)
(2,569)
(2,548)
(1,509)
(2,805)
(1,562)
(408)
(19.1)%
14Net Income
5,237
5,317
6,622
(594)
6,634
7,179
8,001
4,311
8,344
4,614
1,768
(10.3)%
15% Margin
3.4%
3%
3.6%
(0.3)%
2.6%
2.7%
2.7%
1.3%
2.3%
1.2%
0.4%
2.1% A
16Shares Outstanding
1,126
1,079
1,024
1,044
1,305
1,314
1,329
1,323
1,290
1,262
1,271
1.2%
17EPS Basic
4.7
4.9
6.5
(0.6)
5.1
5.5
6
3.3
6.5
3.7
1.4
(11.3)%
18EPS Diluted
4.6
4.9
6.4
(0.6)
5.1
5.5
6
3.3
6.5
3.7
1.4
(11.3)%
19EBITDA
11,567
12,190
11,809
6,743
16,403
17,118
17,526
12,347
18,197
13,683
9,861
(1.6)%
% Margin
7.6%
6.9%
6.4%
3.5%
6.4%
6.4%
6%
3.8%
5.1%
3.7%
2.5%
5.3% A
20Net Interest Income (expense)
(838)
(1,060)
(1,062)
(2,619)
(3,035)
(2,907)
(2,503)
(2,287)
(2,658)
(2,958)
(3,119)
14.1%
21Net Debt / EBITDA
2.2
2
2.1
10.3
5.1
4.5
3.8
4.7
3.9
5.4
8.6
4.8 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,459
3,371
1,696
4,059
5,683
7,854
9,408
12,945
8,196
8,586
8,512
13.2%
23Short-term investments
88
87
111
2,522
2,373
3,000
3,117
2,778
3,259
2,407
2,145
37.6%
24Accounts receivable
11,888
12,164
13,181
17,631
19,617
21,742
24,431
27,276
35,227
36,469
39,779
12.8%
25Other current assets
722
660
945
4,581
5,113
5,277
5,292
3,544
3,151
3,076
5,032
21.4%
26Inventory
14,001
14,760
15,296
16,450
17,516
18,496
17,760
19,090
18,025
18,107
19,246
3.2%
27Total Current Assets
29,158
31,042
31,229
45,243
50,302
56,369
60,008
65,633
67,858
68,645
74,714
9.9%
Non-Current Assets
28Net property, plant & equipment
9,855
10,175
10,292
11,349
32,904
33,335
32,018
30,745
30,435
28,937
28,056
11%
29Long-term investments
-
-
112
15,732
17,314
20,812
23,025
21,096
23,019
28,934
32,869
-
30Other non-current assets
53,424
53,245
53,498
124,132
121,929
120,199
117,948
110,801
128,416
126,699
125,425
8.9%
31Total Non-Current Assets
63,279
63,420
63,902
151,213
172,147
174,346
172,991
162,642
181,870
184,570
186,350
11.4%
Total Assets
92,437
94,462
95,131
196,456
222,449
230,715
232,999
228,275
249,728
253,215
261,064
10.9%
LIABILITIES
Current Liabilities
32Accounts payable
7,490
7,946
8,863
8,925
10,492
11,138
12,544
14,838
14,897
15,892
59,384
23%
33Short-term debt
1,197
1,916
4,821
1,985
5,377
7,078
5,851
3,456
4,713
7,494
5,805
17.1%
34Other current liabilities
14,482
16,388
16,964
33,099
37,434
43,801
49,412
51,127
59,579
61,223
23,503
5%
35Total Current Liabilities
23,169
26,250
30,648
44,009
53,303
62,017
67,807
69,421
79,189
84,609
88,692
14.4%
Non-Current Liabilities
36Long-term debt
26,267
25,615
22,181
71,444
83,625
77,964
70,148
67,276
74,672
75,426
87,788
12.8%
37Other non-current liabilities
5,798
5,763
4,607
22,460
21,351
21,033
19,663
19,809
19,231
17,450
9,202
4.7%
38Total Non-Current Liabilities
32,065
31,378
26,788
93,904
104,976
98,997
89,811
87,085
93,903
92,876
96,990
11.7%
39Total Liabilities
55,234
57,628
57,436
137,913
158,279
161,014
157,618
156,506
173,092
177,485
185,682
12.9%
SHAREHOLDERS` EQUITY
40Common stock
17
17
32,096
45,440
45,972
46,513
47,377
48,193
48,992
18
18
0.6%
41Retained earnings / (deficit)
35,506
38,983
43,556
40,911
45,108
49,640
54,906
56,398
61,604
62,837
61,196
5.6%
42Accumulated other comprehensive income / (loss)
(358)
(305)
(165)
102
1,019
1,414
965
(1,264)
(297)
(120)
406
-
43Noncontrolling interests
7
4
4
318
306
312
306
300
175
170
168
37.4%
44Total shareholders' equity
37,203
36,834
37,695
58,543
64,170
69,701
75,381
71,769
76,636
75,730
75,382
7.3%
45Total Liabilities and shareholders' Equity
92,437
94,462
95,131
196,456
222,449
230,715
232,999
228,275
249,728
253,215
261,064
10.9%
46Total Debt
27,464
27,531
27,002
73,429
89,002
85,042
75,999
70,732
79,385
82,920
93,593
13%
47Net Debt
25,005
24,160
25,306
69,370
83,319
77,188
66,591
57,787
71,189
74,334
85,081
13%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
5,237
5,317
6,622
(594)
6,634
7,179
8,001
4,311
8,344
4,614
1,768
(10.3)%
49Depreciation & amortization
2,092
2,475
2,479
2,718
4,371
4,441
4,486
4,224
4,366
4,597
4,606
8.2%
50Share-based compensation expense
230
222
234
280
453
400
484
447
588
540
535
8.8%
51Changes in working capital and other assets
980
2,127
(1,328)
6,461
1,390
3,845
5,294
7,195
128
(644)
3,730
14.3%
52Net cash flows from operating activities
8,539
10,141
8,007
8,865
12,848
15,865
18,265
16,177
13,426
9,107
10,639
2.2%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(2,367)
(2,224)
(1,918)
(2,037)
(2,457)
(2,437)
(2,520)
(2,727)
(3,031)
(2,781)
(2,832)
1.8%
54Purchases of investments / marketable securities
(267)
(80)
(137)
(692)
(7,534)
(9,639)
(9,963)
(7,746)
(9,043)
(15,191)
(15,012)
49.6%
55Proceeds from maturities of marketable securities
243
91
61
817
7,049
6,467
7,246
6,729
7,729
10,353
12,383
48.2%
56Other investing activities
(11,029)
(257)
(883)
(41,373)
(397)
75
(24)
(1,303)
(16,544)
6
(410)
(28.1)%
57Net cash flows from investing activities
(13,420)
(2,470)
(2,877)
(43,285)
(3,339)
(5,534)
(5,261)
(5,047)
(20,889)
(7,613)
(5,871)
(7.9)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(5,001)
(4,461)
(4,361)
-
-
-
-
(3,500)
(2,012)
(3,023)
394
-
59Dividends paid, net
(1,576)
(1,840)
(2,049)
(2,038)
(2,603)
(2,624)
(2,625)
(2,907)
(3,132)
(3,373)
(3,397)
8%
60Debt issuance (repayments), net
11,218
(614)
(598)
38,265
(5,320)
(5,673)
(9,267)
(4,211)
7,932
5,059
(3,898)
-
61Other financing activities
238
154
257
592
269
601
536
102
(105)
202
1,961
23.5%
62Net cash flows from financing activities
4,879
(6,761)
(6,751)
36,819
(7,654)
(7,696)
(11,356)
(10,516)
2,683
(1,135)
(4,940)
-
63Increase (decrease) in cash and cash equivalents
(22)
912
(1,620)
2,395
1,855
2,635
1,648
614
(4,780)
359
(172)
22.8%
64Cash and equivalents, ending balance
2,459
3,520
1,900
4,295
8,408
11,043
12,691
13,305
8,525
8,884
8,712
13.5%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
6,172
7,917
6,089
6,828
10,391
13,428
15,745
13,450
10,395
6,326
7,807
2.4%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

CVS Health Corporation (CVS) financial statements and performance

Explore CVS Health Corporation (CVS) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.